News Detail
Cambridge, 19 Sept 2023: COVID-19 patients are often prescribed antiviral drugs that work by reducing the number of viral particles circulating in the body. One such drug, View Details
Source : Harvard Gazette
Anne Manning
coronavirus
COVID-19
Department of Organismic and Evolutionary Biology
evolutionary safety
FAS
Martin Nowak
Mathematics
molnupiravir
virus mutations
Related News
- AI-Designed Antivenom Counteracts Toxins from Snakebites (17-01-2025)
- Researchers develop Quantum Dots that can help detect Antibiotics (17-01-2025)
- Feeding your good gut bacteria through fibre in diet may boost body against infections (13-01-2025)
- New combination drug offers treatment against intestinal worms: Lancet (13-01-2025)
- Researchers bypass the liver, delivering genetic drugs to the target location (01-01-2025)
- Study uses AI to cast light on harmful drug-drug interactions (16-12-2024)
- IIT-BHU developing med device with potential to cure sclerosis (28-11-2024)
- Three widely used BP medicines Combo, five times more effective than current drugs (19-11-2024)
- More than half of patients with rheumatic, musculoskeletal disease use OTC supplements: Study (18-11-2024)
- One-third of older people and individuals admitted to the hospital experienced ADRs: Study (17-11-2024)